Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?

Journal of the American College of Cardiology

Volumn 40, Issue 10, 2002, Pages 1748-1754

  Wahab, Nazneem N ^a   Cowden, Elizabeth A ^a   Pearce, Neil J ^a   Gardner, Martin J ^a   Merry, Heather ^a   Cox, Jafna L ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; COHORT STUDIES; ELECTROCARDIOGRAPHY; EVIDENCE-BASED MEDICINE; FEMALE; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NOVA SCOTIA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0037145914     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02483-X     Document Type: Article

References (44)

1. Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease: Therapeutic options in patients with diabetes. J Am Coll Cardiol 2000;36:355-65.
2. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000;356: 773-8.
3. Norhammer AM, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999;22:1827-31.
4. Malmberg K, Norhammer A, Wedel H, Ryden L. Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction. Circulation 1999;99:2626-32.
5. O'Sullivan JJ, Conroy RM, Robinson K, Hickey N, Mulcahy R. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 1991;14:58-60.
6. Fava S, Aquilana O, Azzopardi J, Agius Muscat H, Fenech FF. The prognostic value of blood glucose in diabetic patients with acute myocardial infarction. Diabet Med 1996;13:80-3.
7. Banarjee AK. Blood sugar and prognosis of myocardial infarction in the elderly. Br J Clin Pract 1986;40:516-7.
8. Oswald GA, Corcoran S, Yudkin JS. Prevalence and risks of hyperglycemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1984:1264-7.
9. Ravid M, Berkowicz M, Sohar E. Hyperglycemia during acute myocardial infarction: A six year follow-up study. JAMA 1975;233: 807-9.
10. Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000;102: 1014-9.
11. Lynch M, Gammage MD, Lamb P, Nattrass M, Pentecost BL. Acute myocardial infarction in diabetic patients in the thrombolytic era. Diabet Med 1994;11:162-5.
12. Bellodi G, Manicardi V, Malavasi V, et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989;64:885-8.
13. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinski E, Behar S, and the SPRINT Study Group. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: Incidence, risk factors, and outcome. Am J Med 1993;94:265-73.
14. Oswald GA, Smith CCT, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br J Med 1986;293:917-22.
15. Herlitz J, Bang A, Karlson BW. Mortality, place and mode of death and reinfarction during a period of 5 years after acute myocardial infarction in diabetic and non-diabetic patients. Cardiology. 1996;87: 423-8.
16. Husband DJ, Alberti KG, Julian DG. "Stress" hyperglycaemia during acute myocardial infarction: An indicator of pre-existing diabetes? Lancet 1983;2:179-81.
17. Bolk J, van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Umans VA. Impaired glucose metabolism predicts mortality after myocardial infarction. Int J Cardiol 2001;79:207-14.
18. Gwilt DJ, Petri M, Lamb P, Nattrass M, Pentecost BL. Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction. Br Heart J 1984;51:626-30.
19. Soler NG, Frank S. Value of glycosylated hemoglobin measurements after acute myocardial infarction. JAMA 1981;246:1690-3.
20. Sewardsen M, Vythilingum S, Jialal I, Becker PJ. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. Q J Med 1989;265:461-6.
21. Cox JL, on behalf of the ICONS Investigators. Optimizing disease management at a health care system level: The rationale and methods of the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study. Can J Cardiol 1999;15:787-96.
22. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959-69.
23. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002;25:S1-147.
24. Meltzer S, Leiter L, Daneman D, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ 1998; 159:S1-30.
25. Tenerz A, Lonnberg I, Berne C, Nilsson G, Leppert J. Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J 2001;22:1102-10.
26. Rytter L, Troelsen S, Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 1985;8:230-4.
27. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms of determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997;126:296-306.
28. Haffner SM. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. Endocr Revs 1998;19: 583-92.
29. Tansey MJ, Opie LH. Plasma glucose on admission to hospital as a metabolic index of the severity of acute myocardial infarction. Can J Cardiol 1986;2:326-31.
30. Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998;97:1695-701.
31. Kreisberg RA. Diabetic dyslipidemia. Am J Cardiol 1998;82 Suppl: 67U-73U.
32. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin dependent diabetes mellitus. J Am Coll Cardiol 1996;27:567-74.
33. Holubarsch C, Ruf T, Goldstein DJ, et al. Existence of the Frank-Starling mechanism in the failing human heart: Investigations on the organ, tissue, and sarcomere levels. Circulation 1996;94:683-9.
34. Marcus JT, Gotte MJ, Van Rossum AC, et al. Myocardial function in infarcted and remote regions early after infarction in man: Assessment by magnetic resonance tagging and strain analysis. Magn Reson Med 1997;38:803-10.
35. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-40.
36. Yudkin JS, Oswald GA. Determinant of hospital admission and case fatality in diabetic patients with myocardial infarction. Diabetes Care 1988;11:351-8.
37. Chowdhury TA, Lasker SS. Elevated glycated haemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarction. Postgrad Med J 1998;74:480-1.
38. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infraction in patients with diabetes mellitus. Br Med J 1997;314:1512-5.
39. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
40. Diaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction: The ECLA glucose-insulin potassium pilot trial. Circulation 1998;98:2227-34.
41. Fath-Ordoubadi R, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials. Circulation 1997;96:1152-6.
42. Ceremuzynski L, Budaj A, Czepiel A, et al. Low dose insulin-glucose-potassium is ineffective in acute myocardial infarction: Results of a randomized multicentre Pol GIK trial. Cardioavasc Drug Ther 1999; 13:191-200.
43. Mahon J. Direct and indirect randomized trials of screening: The A's and D's of evidence-based clinical practice guidelines. CMAJ 2000; 162:1002-4.
44. Tuomilehto J, Lindstrom J, Erikkson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.